What is the recommended initial dose of gliclazide modified‑release tablets?

Starting Dose for Gliclazide MR

The recommended starting dose for gliclazide modified-release (MR) is 30 mg once daily, taken with breakfast.

Dosing Algorithm

Initial Dose

• Start at 30 mg once daily with breakfast 1, 2
• The formulation can be taken before, during, or after breakfast without affecting absorption 3
• This initial 30 mg dose provides approximately 50% of the maximum hypoglycemic effect 1

Dose Titration

• Assess response after 2-4 weeks of treatment
• If glycemic control is inadequate, increase to 60 mg once daily 4, 5
• Maximum recommended dose is 120 mg once daily, though optimal efficacy may plateau around 270 mg based on pharmacometric modeling 5
• The modified-release formulation allows for once-daily dosing with consistent 24-hour glucose control 2

Key Clinical Considerations

Advantages of the MR Formulation

• Complete bioavailability (97%) with low to moderate pharmacokinetic variability 3
• Effective glucose reduction at all time points over 24 hours 2
• The equilibration half-life between drug levels and glucose-lowering effect is approximately 3 weeks, meaning full therapeutic effect takes time to develop 1

Special Populations

While the evidence doesn't provide specific MR dosing for special populations, general sulfonylurea principles apply:

• Consider lower starting doses in elderly, malnourished, or those with renal/hepatic impairment
• The newer generation sulfonylureas like gliclazide MR have lower hypoglycemia risk compared to older agents 6

Ramadan Fasting

For patients who fast during Ramadan, switch the morning dose to evening (taken at sunset meal) without dose adjustment 4. This approach maintains safety with very low hypoglycemia risk.

Disease State Impact

The main predictor of response is disease severity 1:

• Patients previously on diet alone or single oral agent: higher response rate
• Patients previously on multiple antidiabetic classes: lower response rate
• Consider more rapid dose escalation in responders to achieve optimal control within the 3-week equilibration period

Common Pitfalls to Avoid

• Don't wait too long to titrate: Given the 3-week equilibration time, assess response at 2-4 weeks and adjust promptly rather than waiting months 1
• Don't assume immediate maximum effect: The full glucose-lowering effect takes approximately 3 weeks to manifest 1
• Don't split the dose: The MR formulation is designed for once-daily administration and maintains 24-hour efficacy 2